miR‑489‑3p inhibits TLR4/NF‑κB signaling to prevent inflammation in psoriasis

Ye,Yujian; Wang,Ping; Zhou,Fangmei

doi:10.3892/etm.2021.10176

miR‑489‑3p inhibits TLR4/NF‑κB signaling to prevent inflammation in psoriasis

Authors:
- Yujian Ye
- Ping Wang
- Fangmei Zhou
View Affiliations

Affiliations: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou, Zhejiang 310009, P.R. China, College of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China
Published online on: May 11, 2021 https://doi.org/10.3892/etm.2021.10176
Article Number: 744
Copyright: © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Psoriasis is a chronic inflammatory skin disease whose etiology has not yet been determined. MicroRNAs (miRs) regulate the early stages of psoriasis and are targets for therapeutic intervention. The present study aimed to investigate the functional role of miR‑489‑3p in psoriasis. The present study first assessed the expression levels of miR‑489‑3p and Toll‑like receptor (TLR)4 mRNA using reverse transcription‑quantitative PCR, and also detected the protein expression levels of TLR4 and NF‑κB via western blot analysis. TargetScan and miRDB target gene prediction tools were used to confirm the regulation of Toll‑like receptor (TLR)4 by miR‑489‑3p. Moreover, a Cell Counting Kit (CCK)‑8 assay was conducted to evaluate cell viability, while cell cycle and colony formation assays were performed to evaluate cell proliferation. Human keratinocytes (HaCaT) were co‑transfected with TLR4‑small interfering RNA and miR‑489‑3p‑inhibitor plasmids, and analysis of cell proliferation and inflammatory cytokine secretion was performed using CCK‑8 assay and ELISA. It was found that miR‑489‑3p expression was downregulated in patients with psoriasis. Bioinformatics analysis identified that TLR4 was a direct target of miR‑489‑3p. This was confirmed via luciferase reporter assays in HaCaT cells. The overexpression of miR‑489‑3p inhibited the TLR4/NF‑κB signaling pathway and reduced cell proliferation. TLR4 silencing alleviated the effects of miR‑489‑3p, and enhanced cell proliferation and inflammatory cytokine secretion. Taken together, these data suggested that miR‑489‑3p may be a key effector of psoriasis, which promotes inflammatory responses by direct targeting of TLR4. miR‑489‑3p therefore represents a promising prognostic biomarker and therapeutic target for psoriasis treatment.

View Figures

View References

1	Langley RG, Krueger GG and Griffiths CE: Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis. 64 (Suppl 2):ii18–ii25. 2005.PubMed/NCBI View Article : Google Scholar
2	Zhang K and Shen ZA: Research advances on immunological properties and gene regulation of skin keratinocytes. Zhonghua Shao Shang Za Zhi. 37:89–92. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
3	Lowes MA, Bowcock AM and Krueger JG: Pathogenesis and therapy of psoriasis. Nature. 445:866–873. 2007.PubMed/NCBI View Article : Google Scholar
4	Qureshi AA, Choi HK, Setty AR and Curhan GC: Psoriasis and the risk of diabetes and hypertension: A prospective study of US female nurses. Arch Dermatol. 145:379–382. 2009.PubMed/NCBI View Article : Google Scholar
5	Guttman-Yassky E, Nograles KE and Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: Clinical and pathologic concepts. J Allergy Clin Immunol. 127:1110–1118. 2011.PubMed/NCBI View Article : Google Scholar
6	Rizwan M and Khan A: Association of psoriasis and serum uric acid levels: A case control study. Pakistan Armed Forces Med J. 69:408–412. 2019.
7	Pradyuth S, Rapalli VK, Gorantla S, Waghule T, Dubey SK and Singhvi G: Insightful exploring of microRNAs in psoriasis and its targeted topical delivery. Dermatol Ther. 33(e14221)2020.PubMed/NCBI View Article : Google Scholar
8	Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524. 2006.PubMed/NCBI View Article : Google Scholar
9	Rebane A and Akdis CA: MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol. 132:15–26. 2013.PubMed/NCBI View Article : Google Scholar
10	Chang L, Liang J, Xia X and Chen X: miRNA-126 enhances viability, colony formation, and migration of keratinocytes HaCaT cells by regulating PI3 K/AKT signaling pathway. Cell Biol Int. 43:182–191. 2019.PubMed/NCBI View Article : Google Scholar
11	Covert MW, Leung TH, Gaston JE and Baltimore D: Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science. 309:1854–1857. 2005.PubMed/NCBI View Article : Google Scholar
12	Kyriakis JM and Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 81:807–869. 2001.PubMed/NCBI View Article : Google Scholar
13	Wei W, Dejie L, Xiaojing S, Tiancheng W, Yongguo C, Zhengtao Y and Naisheng Z: Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model. Inflammation. 38:16–26. 2015.PubMed/NCBI View Article : Google Scholar
14	Lowes MA, Suárez-Fariñas M and Krueger JG: Immunology of psoriasis. Annu Rev Immunol. 32:227–255. 2014.PubMed/NCBI View Article : Google Scholar
15	Zhang C, Xiao C, Dang E, Cao J, Zhu Z, Fu M, Yao X, Liu Y, Jin B, Wang G and Li W: CD100-Plexin-B2 promotes the inflammation in psoriasis by activating NF-κB and the inflammasome in keratinocytes. J Invest Dermatol. 138:375–383. 2018.PubMed/NCBI View Article : Google Scholar
16	Wu AG, Conway J, Barazani L, Roy B, Cline A and Pereira F: Is clear always clear? Comparison of psoriasis area and severity index (PASI) and the Physician's global assessment (PGA) in psoriasis clearance. Dermatol Ther (Heidelb). 10:1155–1163. 2020.PubMed/NCBI View Article : Google Scholar
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
18	Cai Y, Fleming C and Yan J: New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 9:302–309. 2012.PubMed/NCBI View Article : Google Scholar
19	Griffiths CE and Barker JN: Pathogenesis and clinical features of psoriasis. Lancet. 370:263–271. 2007.PubMed/NCBI View Article : Google Scholar
20	Han G, Williams CA, Salter K, Garl PJ, Li AG and Wang XJ: A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol. 130:371–377. 2010.PubMed/NCBI View Article : Google Scholar
21	Tattersall D, Scott CA, Gray C, Zicha D and Kelsell DP: EKV mutant connexin 31 associated cell death is mediated by ER stress. Hum Mol Genet. 18:4734–4745. 2009.PubMed/NCBI View Article : Google Scholar
22	Kalali BN, Köllisch G, Mages J, Müller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M and Ollert M: Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol. 181:2694–2704. 2008.PubMed/NCBI View Article : Google Scholar
23	Aldehlawi H, Usman S, Lalli A, Ahmad F, Williams G, Teh MT and Waseem A: Serum lipids, retinoic acid and phenol red differentially regulate expression of keratins K1, K10 and K2 in cultured keratinocytes. Sci Rep. 10(4829)2020.PubMed/NCBI View Article : Google Scholar
24	Ni X and Lai Y: Keratinocyte: A trigger or an executor of psoriasis? J Leukoc Biol. 108:485–491. 2020.PubMed/NCBI View Article : Google Scholar
25	Tsuru Y, Jinnin M, Ichihara A, Fujisawa A, Moriya C, Sakai K, Fukushima S and Ihn H: miR-424 levels in hair shaft are increased in psoriatic patients. J Dermatol. 41:382–385. 2014.PubMed/NCBI View Article : Google Scholar
26	Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, Ståhle M, Sonkoly E and Pivarcsi A: MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 131:1521–1529. 2011.PubMed/NCBI View Article : Google Scholar
27	Li J, Qu W, Jiang Y, Sun Y, Cheng Y, Zou T and Du S: miR-489 suppresses proliferation and invasion of human bladder cancer cells. Oncol Res. 24:391–398. 2016.PubMed/NCBI View Article : Google Scholar
28	Liu Q, Yang G and Qian Y: Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway. Mol Carcinog. 56:1312–1321. 2017.PubMed/NCBI View Article : Google Scholar
29	Jiang R, Zhang C, Gu R and Wu H: MicroRNA-489-3p inhibits neurite growth by regulating PI3K/AKT pathway in spinal cord injury. Pharmazie. 72:272–278. 2017.PubMed/NCBI View Article : Google Scholar
30	Banerjee S, Thompson WE and Chowdhury I: Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. Front Biosci (Landmark Ed). 26:771–796. 2021.PubMed/NCBI
31	Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K and Akira S: TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 4:1144–1150. 2003.PubMed/NCBI View Article : Google Scholar
32	Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M and Arditi M: Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 275:11058–11063. 2000.PubMed/NCBI View Article : Google Scholar
33	Muzio M, Natoli G, Saccani S, Levrero M and Mantovani A: The human Toll signaling pathway: Divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med. 187:2097–2101. 1998.PubMed/NCBI View Article : Google Scholar
34	Hayden MS and Ghosh S: . NF-κB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev. 26:203–234. 2012.PubMed/NCBI View Article : Google Scholar
35	Vallabhapurapu S and Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Ann Rev Immunol. 27:693–733. 2009.PubMed/NCBI View Article : Google Scholar
36	Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z, Cheng Y, Li Y, Peng X and Cha X: ‘Psoriasis 1’ reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF-κB and STAT signaling pathways. Mol Med Rep. 18:2733–2743. 2018.PubMed/NCBI View Article : Google Scholar
37	Pivarcsi A, Meisgen F, Xu N, Ståhle M and Sonkoly E: Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. Br J Dermatol. 169:563–570. 2013.PubMed/NCBI View Article : Google Scholar
38	Loubaki L, Chabot D, Paré I, Drouin M and Bazin R: MiR-146a potentially promotes IVIg-mediated inhibition of TLR4 signaling in LPS-activated human monocytes. Immunol Lett. 185:64–73. 2017.PubMed/NCBI View Article : Google Scholar
39	Liu AH, Wu YT and Wang YP: MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-κB signaling pathway. Brain Res Bull. 132:139–149. 2017.PubMed/NCBI View Article : Google Scholar
40	Nicolas JF: Psoriasis: How the epithelium influences the immune response: Keratinocytes, dendritic cells and T lymphocytes. Bull Acad Natl Med. 198:17–30. 2014.PubMed/NCBI(In French).